Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patient…
$93.86+6.25%
报价 2026-11-06
市值
$7.37B
EV
$7.17B
PE (TTM)
64.5x
预期 PE
–
52 周区间距高点 -3.8%
$37.92$97.56
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| KNSAKiniksa Pharmaceuticals, Ltd. | $7.37B | +6.2% | – | 54.3% | 64.5x | 49.8x | 36.8x | |
| CORTCorcept Therapeutics Incorporated | $7.87B | +1.6% | +19.7% | 98.3% | 218.0x | 422.2x | 114.6x | |
| PRAXPraxis Precision Medicines, Inc. | $7.75B | +5.7% | +1400.0% | 0% | – | – | – | |
| RYTMRhythm Pharmaceuticals, Inc. | $7.73B | +6.9% | +57.7% | 88.2% | – | – | – | |
| ALKSAlkermes plc | $7.7B | +3.1% | – | 86.6% | 55.6x | 35.6x | – | |
| ABVXAbivax S.A. | $7.5B | +1.8% | – | 0% | – | – | – | |
| CYTKCytokinetics, Incorporated | $7.46B | -3.3% | +35.4% | -22.3% | – | – | – | |
| CAICaris Life Sciences, Inc. | $7.13B | -3.1% | +32.3% | 69.7% | 80.6x | 47.7x | 57.9x | |
| AXSMAxsome Therapeutics, Inc. | $6.96B | +2.0% | +54.8% | 92.6% | – | – | – | |
| 同行中位数 | – | – | +45.1% | 78.1% | 80.6x | 47.7x | 86.2x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。